Clinical trial
Randomized, Open Label, Prospective Study on the Efficacy and Safety of Dextenza Compared to Topical Fluorometholone in Patients With Ocular Rosacea (ROSE Study)
NCT04839549 is registered in ClinicalTrials.gov with Eye Associates of Central Texas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Open Label, Prospective Study on the Efficacy and Safety of Dextenza Compared to Topical Fluorometholone in Patients With Ocular Rosacea (ROSE Study)
- Lead sponsor
- Eye Associates of Central Texas
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- June 6, 2020
- Completion date
- November 29, 2022
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
ocular rosacea